Molina Healthcare (NYSE:MOH) Releases FY 2025 Earnings Guidance

Molina Healthcare (NYSE:MOH) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 24.500- for the period, compared to the consensus EPS estimate of 26.070. The company issued revenue guidance of -.

Molina Healthcare Stock Up 0.7 %

MOH traded up $2.07 during trading on Friday, hitting $287.08. The stock had a trading volume of 378,081 shares, compared to its average volume of 606,493. The stock has a 50 day simple moving average of $298.78 and a two-hundred day simple moving average of $318.38. The company has a market capitalization of $16.42 billion, a PE ratio of 14.58, a PEG ratio of 0.96 and a beta of 0.54. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54. Molina Healthcare has a twelve month low of $272.69 and a twelve month high of $423.92.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.92% and a return on equity of 27.88%. On average, research analysts predict that Molina Healthcare will post 23.44 earnings per share for the current year.

Wall Street Analysts Forecast Growth

MOH has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price objective on Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a research report on Monday, November 4th. StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 31st. Barclays increased their price target on shares of Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a research report on Friday, October 25th. Truist Financial reduced their price objective on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Stephens reaffirmed an “equal weight” rating and issued a $345.00 target price on shares of Molina Healthcare in a report on Thursday. One analyst has rated the stock with a sell rating, seven have given a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $358.42.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.